X
Get new exclusive access to healthcare business reports & breaking news
Andreea Ciulac Andreea Ciulac is former Chicago Tribune writer with almost a decade of reporting experience. She has a knack for deciphering complex medical reports and statistics and conveying them into engaging stories that will help executives in healthcare keep up with the digital transformations in their industry. She covers an array of topics from pharma to startups and the Illinois healthcare system.
The U.S. Food and Drug Administration (FDA) has lifted a partial clinical hold on Epizyme’s tazemetostat trials, a ...
